Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027560
Status:
COMPLETED
Last Update Posted:
2013-01-07
First Post:
2001-12-07
Brief Title:
Melphalan Fludarabine and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center